// App-Quantinova.ai

7068 : Clinical features and outcome of patients with poor-prognosis myelofibrosis based on platelet count <50 x 109/L: A single-center experience in 1100 myelofibrosis patients.

Researchers

Presenter

  • Ahmad Alhuraiji

Principal Investigators

  • Lucia Masarova

  • Prithviraj Bose

  • Naval Guastad Daver

  • Jorge E. Cortes

  • Sherry Pierce

  • Hagop M. Kantarjian

  • Srdan Verstovsek

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Essential thrombocythemia

  • Polycythemia vera

  • Myelofibrosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved